NEW YORK, Jan. 7—Idec Pharmaceuticals and ExonHit Therapeutics said Monday that they would collaborate to develop new antigen targets for antibody therapy.
NEW YORK, Jan. 7—Idec Pharmaceuticals and ExonHit Therapeutics said Monday that they would collaborate to develop new antigen targets for antibody therapy.